Search - tctmd.com

Displaying 1 - 20 of 72

Sort: Relevancy | Date

Presentation TCT 2024

Real World TTVI Registries vs. Randomized Trials: Are the Outcomes Aligned?

Presenter: Brian Whisenant

October 30, 2024

News Conference News NY Valves 2024

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

Todd Neale

June 07, 2024

Presentation NY Valves 2024

Critical Appraisal of the FDA Trials … TRISCEND II (tricuspid TVR) – Can We Balance the Complications?

Presenter: Brian K. Whisenant

June 07, 2024

Presentation NY Valves 2024

Topline Results from the TRILUMINATE Transcatheter Tricuspid Edge-to-Edge Repair Trial

Presenter: Brian K. Whisenant

June 07, 2024

Presentation NY Valves 2024

T-TEER in a Broad Range of Anatomies: Results From the TRILUMINATE Pivotal Trial

Presenter: Brian K. Whisenant

June 06, 2024

News Conference News TCT 2023

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Yael L. Maxwell

November 02, 2023

Presentation TCT 2023

LVOT Management

Presenter: Brian Whisenant

October 25, 2023

Presentation TCT 2022

MAC and Small Valve Areas

Presenter: Brian K. Whisenant

September 19, 2022

Presentation TCT 2022

The Argument for a TEER Trial in the FMR Space – CLASP IIF

Presenter: Brian Whisenant

September 18, 2022

Presentation TCT 2022

Valve in Bioprosthetic Mitral Failure: Technical Considerations, Outcomes, and Complications

Presenter: Brian Whisenant

September 17, 2022

Presentation TVT 2022

Perspective 2: Annular Reduction Will Usually Be Needed, Stand-Alone or Complementing TEER!

Presenter: Brian Whisenant

June 08, 2022

Presentation TCT 2021

Closing Complex Anatomies LAAO Devices

Presenter: Brian Whisenant

November 06, 2021

Presentation TCT 2021

Reconciling Anatomical Indications With TMVR Technical Advantages and Limitations

Presenter: Brian Whisenant

November 05, 2021

News Daily News

Good Outcomes With Transcatheter Mitral Valve-in-Valve, With Caveats

Todd Neale

July 31, 2020

Presentation TCT 2019

TCT 8: Updated 30-Day Outcomes for the U.S. Early Feasibility Study of the SAPIEN M3 Transcatheter Mitral Valve Replacement System

Presenter: Brian Whisenant

September 28, 2019

Presentation TCT 2019

Direct Annuloplasty: Cardioband and Millipede — Device Description, Results, and Ongoing Studies

Presenter: Brian Whisenant

September 27, 2019

Presentation TCT 2019

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Presenter: Brian Whisenant

September 26, 2019

News Conference News TVT 2019

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Michael O'Riordan

June 14, 2019

Presentation TVT 2019

Treating a Stentless Bioprosthetic Surgical Valve

Presenter: Brian Whisenant

June 14, 2019

Presentation TVT 2019

Expanding the Clinical Indications for LAA Closure: Challenges, Alternative Therapies, and Vision

Presenter: Brian Whisenant

June 14, 2019

Advertisement

Real World TTVI Registries vs. Randomized Trials: Are the Outcomes Aligned?

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

Critical Appraisal of the FDA Trials … TRISCEND II (tricuspid TVR) – Can We Balance the Complications?

Topline Results from the TRILUMINATE Transcatheter Tricuspid Edge-to-Edge Repair Trial

T-TEER in a Broad Range of Anatomies: Results From the TRILUMINATE Pivotal Trial

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

LVOT Management

MAC and Small Valve Areas

The Argument for a TEER Trial in the FMR Space – CLASP IIF

Valve in Bioprosthetic Mitral Failure: Technical Considerations, Outcomes, and Complications

Perspective 2: Annular Reduction Will Usually Be Needed, Stand-Alone or Complementing TEER!

Closing Complex Anatomies LAAO Devices

Reconciling Anatomical Indications With TMVR Technical Advantages and Limitations

Good Outcomes With Transcatheter Mitral Valve-in-Valve, With Caveats

TCT 8: Updated 30-Day Outcomes for the U.S. Early Feasibility Study of the SAPIEN M3 Transcatheter Mitral Valve Replacement System

Direct Annuloplasty: Cardioband and Millipede — Device Description, Results, and Ongoing Studies

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Treating a Stentless Bioprosthetic Surgical Valve

Expanding the Clinical Indications for LAA Closure: Challenges, Alternative Therapies, and Vision

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content